Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab Users

Arthritis Rheumatol. 2023 Nov;75(11):1904-1906. doi: 10.1002/art.42562. Epub 2023 Aug 22.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Humans
  • Pneumonia, Pneumocystis* / drug therapy
  • Pneumonia, Pneumocystis* / prevention & control
  • Risk Assessment
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • Cyclophosphamide